Now available BEYFORTUS™

BEYFORTUS™ (nirsevimab-alip) injection, for intramuscular use, is a respiratory syncytial virus (RSV) F protein-directed fusion inhibitor indicated for the prevention of RSV lower respiratory tract disease in:

- Neonates and infants born during or entering their first RSV season. 

- Children up to 24 months of age who remain vulnerable to severe RSV disease through their second
RSV season.